While cancer cells acquire malignant traits through epigenetic remodeling, it remains unclear how immune-derived inflammatory factors regulate the epigenetics of colorectal cancer cells.

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest moments—revealing how lung cells with cancer-causing mutations recruit ...

Immune checkpoint inhibitors have revolutionized cancer treatment, yet many colorectal tumors remain resistant. Even among ...

Scientists developed a new CRISPR technology that targets specific RNA molecules. This breakthrough allows for the selective destruction of diseased human cells. The Cas12a2 system differs from Cas9 ...

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole chromosomes, changes that help tumors grow, adapt and resist treatment. In ...

Add Yahoo as a preferred source to see more of our stories on Google. Haylie Helms, M.S., an OHSU graduate student in biomedical engineering, is lead author on a review in Nature Reviews. Helms works ...

A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found. A colorized three dimensional micrographic scan of a melanoma cell. Recent ...

Part of the challenge is the environment in which cancer cells exist. Inside the body, tumors are constantly bathed in ...

Liver metastases are among the most common and deadly forms of cancer spread. Now, researchers at VIB and KU Leuven, with ...

Researchers showed that chemotherapy-resistant cancer cells use fructose to reprogram neighboring cells and facilitate ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor’s earliest moments — revealing how lung cells with cancer-causing mutations recruit ...